Administrative Core
行政核心
基本信息
- 批准号:10171143
- 负责人:
- 金额:$ 31.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-18 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Administrative CoordinationAdvocateAreaBiotechnologyBudgetsClinical TrialsCollaborationsCommittee MembersCommunicationCommunitiesCommunity Clinical Oncology ProgramComprehensive Cancer CenterDataDevelopmentEducational workshopEnsureEnvironmentEvaluationEventExpenditureFosteringFundingHuman Subject ResearchIndividualInstitutesInstitutionLeadershipMalignant NeoplasmsMalignant neoplasm of ovaryManuscriptsMonitorNational Cancer InstituteOccupational activity of managing financesOffice of Administrative ManagementPatientsPerformancePharmacologic SubstancePoliciesPreparationProductivityProgress ReportsPublicationsRegulationReportingResearchResearch PersonnelResourcesRiskSafetyServicesTranslational ResearchTravelUnited States National Institutes of HealthUniversitiesWorkanticancer researchcareercostexperiencehuman subject protectionmeetingsprogramsquality assurance
项目摘要
ABSTRACT
The overall objective of the Roswell Park Ovarian Cancer SPORE Administration Core is to provide leadership,
direction, scientific and fiscal oversight, and administrative services for the purposes of enhancing research
productivity and maintaining a stimulating research environment conducive to translational research in ovarian
cancer. Importantly, the Administration Core will catalyze, oversee, and support interactions amongst SPORE
components, external and internal collaborators, other SPOREs, patient advocates, and the National Cancer
Institute (NCI). In order to achieve the overall objective of managing SPORE resources and maintaining high
quality in all components, the Administration Core will be organized into four main operational areas, the
provision of 1) Leadership; 2) Administrative Management; 3) Clinical Trials, Data, and Communications
Management; and 4) Scientific Management. This management and support is accomplished through an
organizational framework that takes advantage of highly experienced leadership that is integrated within
Roswell Park Comprehensive Cancer Center, an oversight executive committee for planning and evaluation of
activities, and scientific and patient advocate advisors. The functions performed by the Administration Core will
provide greater integration and efficiency across the program and will result in lower operating costs for each
individual Roswell Park Ovarian Cancer SPORE component.
摘要
罗斯威尔公园卵巢癌孢子管理核心的总体目标是提供领导,
指导、科学和财政监督以及行政服务,以加强研究
生产力和维持一个刺激的研究环境,有利于转化研究卵巢癌
癌重要的是,管理核心将促进、监督和支持SPORE之间的互动
组成部分,外部和内部合作者,其他SPORE,患者倡导者和国家癌症研究所
研究所(NCI)。为了实现管理SPORE资源和保持高质量的总体目标,
为了提高所有组成部分的质量,行政核心将分为四个主要业务领域,
提供1)领导; 2)行政管理; 3)临床试验、数据和通信
(四)科学管理。这种管理和支持是通过
组织框架,利用经验丰富的领导,是集成在
罗斯威尔公园综合癌症中心,一个监督执行委员会,负责规划和评估
活动,以及科学和病人倡导顾问。行政核心履行的职能将
在整个计划中提供更大的集成和效率,并将降低每个项目的运营成本
罗斯威尔公园卵巢癌孢子成分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KUNLE O. ODUNSI其他文献
KUNLE O. ODUNSI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KUNLE O. ODUNSI', 18)}}的其他基金
Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity
抑制吲哚胺2,3双加氧酶增强卵巢肿瘤免疫
- 批准号:
8485806 - 财政年份:2013
- 资助金额:
$ 31.06万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 31.06万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 31.06万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 31.06万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 31.06万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 31.06万 - 项目类别: